GlassScriptPhysician profile
Lawrence-Stuart M Cruz
NPI 1760867246
$5,070.95
in general payments reported to CMS, 2019-2025
14 companies · $1,409 in 2025
The $1,409 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $93.21 · 2021: $197 · 2022: $574 · 2023: $1,651 · 2024: $610 · 2025: $1,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,476 · Travel and Lodging: $774 · Consulting Fee: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,475.62 |
| Travel and Lodging | $774.36 |
| Consulting Fee | $420.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,480.34 | 2023-2025 | Precision7, Precision 1, Total30 |
| Tarsus Pharmaceuticals, INC. | $1,045.78 | 2024-2025 | Xdemvy |
| Coopervision INC. | $789.37 | 2019-2025 | Misight Contact Lens, Cvi Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $332.87 | 2023-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $262.35 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $260.37 | 2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $251.92 | 2020-2022 | |
| Allergan, INC. | $146.89 | 2022 | |
| Sight Sciences, INC. | $125.58 | 2023 | Tearcare System |
| Shire North American Group INC | $124.97 | 2019 | |
| Astellas Pharma US INC | $121.80 | 2023 | |
| Maculogix, INC. | $70.59 | 2021 | |
| Abbvie INC. | $42.05 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $16.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence-Stuart Cruz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.